Table 2.

Univariate analysis of 14-day mortality in patients with CRAB bacteremia.

Patient characteristics	Survivors (n = 44)	Non-survivors (n = 27)	p
Age, years	65.34 ± 15.70	69.62 ± 12.77	0.23
Sex, male	22 (50%)	20 (74.1%)	0.05
Diabetes mellitus	20 (45.5%)	8 (29.6%)	0.21
Cardiovascular disease	8 (29.6%)	9 (20.5%)	0.40
Chronic lung disease	9 (20.5%)	11 (40.7%)	0.10
Renal impairment	13 (29.5%)	9 (33.3%)	0.79
Chronic liver disease	6 (13.6%)	5 (18.5%)	0.73
Cerebrovascular disease	24 (54.5%)	6 (22.2%)	0.01
Malignancy	9 (20.5%)	6 (22.2%)	1.00
Pitt bacteremia score	3.25 ± 2.22	5.22 ± 2.22	0.001
Steroid/immunosuppressant use	9 (20.5%)	4 (14.8%)	0.75
Recent surgery	15 (34.1%)	6 (22.2%)	0.42
CVC	39 (88.6%)	25 (92.6%)	0.70
Type of infection
Pneumonia	13 (29.5%)	18 (66.7%)	0.003
CRI	19 (43.2%)	8 (29.6%)	0.31
SSTI	6 (13.6%)	1 (3.7%)	0.24
IAI	3 (6.8%)	0 (0)	0.28
UTI	1 (2.3%)	0 (0)	1.00
PB	1 (2.3%)	0 (0)	1.00
CNS infection	1 (2.3%)	0 (0)	1.00
Combination therapy	23 (52.3%)	8 (29.6%)	0.08

Data are presented as mean ± standard deviation, SD for continuous variables and as n (%) of patients for categorical variables. CVC, central venous catheter; CRI, central line associated infection; UTI, urinary tract infection; SSTI, skin and soft tissue infection; IAI, intra-abdominal infection; PB, primary bacteremia; CNS, central nervous system.